- Home
- RFL vs ONDS Comparison
RFL vs ONDS Comparison
Compare RFL & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- ONDS
- Stock Information
- Founded
- RFL 2017
- ONDS 2014
- Country
- RFL United States
- ONDS United States
- Employees
- RFL N/A
- ONDS N/A
- Industry
- RFL Real Estate
- ONDS Telecommunications Equipment
- Sector
- RFL Finance
- ONDS Telecommunications
- Exchange
- RFL Nasdaq
- ONDS Nasdaq
- Market Cap
- RFL 55.3M
- ONDS N/A
- IPO Year
- RFL N/A
- ONDS N/A
- Fundamental
- Price
- RFL $1.92
- ONDS $1.47
- Analyst Decision
- RFL
- ONDS Strong Buy
- Analyst Count
- RFL 0
- ONDS 2
- Target Price
- RFL N/A
- ONDS $2.50
- AVG Volume (30 Days)
- RFL 27.8K
- ONDS 6.2M
- Earning Date
- RFL 12-27-2024
- ONDS 11-12-2024
- Dividend Yield
- RFL N/A
- ONDS N/A
- EPS Growth
- RFL N/A
- ONDS N/A
- EPS
- RFL N/A
- ONDS N/A
- Revenue
- RFL $697,000.00
- ONDS $8,024,937.00
- Revenue This Year
- RFL N/A
- ONDS N/A
- Revenue Next Year
- RFL N/A
- ONDS $255.67
- P/E Ratio
- RFL N/A
- ONDS N/A
- Revenue Growth
- RFL 151.62
- ONDS N/A
- 52 Week Low
- RFL $1.29
- ONDS $0.54
- 52 Week High
- RFL $2.50
- ONDS $1.99
- Technical
- Relative Strength Index (RSI)
- RFL 53.58
- ONDS 65.28
- Support Level
- RFL $1.71
- ONDS $1.06
- Resistance Level
- RFL $1.92
- ONDS $1.88
- Average True Range (ATR)
- RFL 0.10
- ONDS 0.27
- MACD
- RFL -0.00
- ONDS 0.06
- Stochastic Oscillator
- RFL 84.00
- ONDS 66.11
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.